Search Results

1-20 of 1,232 results for subject:"Medical treatments"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

Deposited Paper HINF 2003/2645

Deposited by

Department of Health

Type

Deposited papers

Date

24 December 2003

Reference

HINF 2003/2645

House

House of Commons

Deposited Paper HINF 2003/2841

Deposited by

Home Office

Type

Deposited papers

Date

23 December 2003

Reference

HINF 2003/2841

House

House of Commons

Dept for International Development

To ask the Secretary of State for International Development, if he will make a statement on shortages of (a) antisera (anti-snake venom) and (b) anti-cancer medicines in Iraq. - Inc figures.

Asked by

Tom Brake (Liberal Democrat)

Answering body

Department for International Development

Type

Written questions

Status

Answered

Tabled on

9 December 2003

For answer on

18 December 2003

Answered on

18 December 2003

Tom Brake: To ask the Secretary of State for International Development if he will make a statement on shortages of (a) antisera (anti-snake venom) and (b) anti-cancer medicines in Iraq. [143935] Hilary Benn: Assessments by the World Health Organisation (WHO) and the Iraqi Ministry of Health earlier in the autumn indicated that there are no major shortages of essential medical supplies in Iraq. There are however still reported shortages of some very specialised supplies including antisera (ie anti snake venom) and some anti-cancer medicines. A great deal has already been achieved to re-establish drug systems in Iraq. The initial focus was, rightly, on securing adequate supplies of the most essential and most used medicines and vaccines. On 27 October, the Iraqi Ministry of Health estimated that 15,000 tons of pharmaceuticals and medical supplies had been delivered in 150 days. However, new supply systems are not yet fully operational. Until these are in place, including comprehensive accounting and reporting processes to ensure that needs are identified before shortages arise, some problems will continue to occur. Work is currently underway in the Iraqi Ministry of Health to develop a national drug formulary. This will enable improved sourcing of drugs and a new purchasing structure which will facilitate the arrival of some drugs which were almost non-existent under the old regime, including top-tier cancer drugs and other advanced pharmaceuticals. Work is also being done by the Ministry of Health, CPA and WHO to develop a complete overview of missing drugs and supplies. This is scheduled to finish in three months.

Date

18 December 2003

Reference

143935; 415 c1004-5W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what his policy is towards new treatments which allow patients to self-administer at home; what steps he is taking to help patients access new treatments which allow them to self-administer their treatment at home when recommended by their clinician. - Including ref...

Asked by

Andy King (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

415 c1134W; 144549;144550

House

House of Commons

Warner, Lord

What public funding is currently directed to research into Huntington's disease; and what progress has been made in research leading to curing or arresting the spread of Huntingdon's disease in individual sufferers. - Inc figures. [HL 375] [HL 378].

Asked by

Lord Jopling (Conservative)

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

HL 375; 655 c185WA

House

House of Lords

Dept of Health

To ask the Secretary of State for Health, what steps are being taken to inform cancer patients about the alternatives to blood transfusion for chemotherapy-induced anaemia.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

144495; 415 c1118W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many patients received blood transfusions for chemotherapy-induced anaemia in each year since 1997. - Not collected centrally.

Asked by

Dai Havard (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

144494; 415 c1118W

House

House of Commons

Dept for Constitutional Affairs

To ask the Parliamentary Secretary, Department for Constitutional Affairs, what account is being taken in the Draft Mental Incapacity Bill of measures to improve support for people with learning disabilities requiring help to reach decisions affecting their future health needs.

Asked by

David Drew (Labour; Co-operative Party)

Answering body

Department for Constitutional Affairs

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

415 c1117W; 144958

House

House of Commons

Northern Ireland Office

To ask the Secretary of State for Northern Ireland, how many people in Northern Ireland are diagnosed with arrhythmia; what steps he is taking to raise awareness of this condition in Northern Ireland; and if he will make a statement.

Asked by

Lady Hermon (Ulster Unionist Party)

Answering body

Northern Ireland Office

Type

Written questions

Status

Answered

Date

18 December 2003

Reference

145070; 415 c1077W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what provisions in the National Service Framework for long-term conditions will address the needs of long-term epilepsy sufferers; what progress he has made in addressing the concerns raised in the National Sentinel Clinical Audit of Epilepsy-related Death, published in May 2002.

Asked by

John Baron (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 December 2003

For answer on

17 December 2003

Answered on

17 December 2003

Mr. Baron: To ask the Secretary of State for Health (1) what provisions in the National Service Framework for long-term conditions will address the needs of long- term epilepsy sufferers; [144703] (2) what progress he has made in addressing the concerns raised in the National Sentinel Clinical Audit of Epilepsy-related Death, published in May 2002. [144704] Dr. Ladyman: In February 2003, we published an action plan for epilepsy services which addresses the key recommendations in the National Clinical Audit of Epilepsy Related Deaths audit and the Chief Medical Officer's 2001 Annual Report on epilepsy. This will be complemented by two key initiatives, which are planned for publication next year. The National Institute for Clinical Excellence (NICE) is developing a clinical guideline for the diagnosis, management and treatment of epilepsy, which it plans to publish next July. It is also looking at the clinical and cost effectiveness of new anti- epilepsy drugs in children and adults and plans to publish an appraisal in the new year. These will help address any variations in clinical practice and contribute to the improvement of services. We are developing the national service framework (NSF) for long-term conditions, which will focus on improving the standard of general neurology care across England for people with conditions such as epilepsy. The NSF will address a range of key issues, for example: the need for equitable access to a range of services; good quality information and support, for patients and carers; the ability to see a specialist and get the right investigations and diagnosis as quickly as possible; and, maintaining independence and quality of life. We currently plan to publish the NSF late next year for implementation over 10 years from 2005.

Date

17 December 2003

Reference

415 c992W; 144703;144704

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many primary care trust, collaborative commissioning groups are providing funding for the treatment of rheumatoid arthritis - Inc fact that info requested is not collected centrally.

Asked by

Andy King (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 December 2003

Reference

144548; 415 c1000W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps are taken to ensure that the use of medication for women in prison complies with the best practice guidance of the NHS.

Asked by

Julie Morgan (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 December 2003

Reference

415 c1000W; 144520

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what action the Government is taking to promote effective inter-agency arrangements for dealing with mentally disordered offenders.

Asked by

Julie Morgan (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

10 December 2003

For answer on

17 December 2003

Answered on

17 December 2003

Julie Morgan: To ask the Secretary of State for Health what action the Government are taking to promote effective inter-agency arrangements for dealing with mentally disordered offenders. [144072] Ms Rosie Winterton: The Government are committed both to providing better services for people with mental health problems and to protecting the public from crime and the fear of crime. A number of initiatives to support these aims are underway, involving a number of Government departments to tackle the issues raised by mentally disordered offenders. The Department of Health, the Home Office and the Prison Service are developing new assessment and treatment facilities for dangerous people with severe personality disorder. This will result in 300 new places becoming available in high secure care with the development of an infrastructure at lower levels of security to allow a safe transition for those whose risk is reduced. Multi-agency public protection arrangements exist in every part of the country and bring together health, police, probation and other agencies to plan the management of people who pose a risk in the community, many of whom are mentally disordered offenders. Closer working between social services departments and mental health trusts, often leading to single management, has benefited all mental health services, including mentally disordered offenders by removing the traditional boundaries between health and social care. Court liaison and diversion schemes are widespread and act to ensure that mentally ill people who come into contact with the Criminal Justice System receive mental health care whenever possible. A number of strands of work are underway with the National Probation Service to ensure that they are supported by mental health services while managing people with mental health problems in hostels and the community.

Date

17 December 2003

Reference

415 c999-1000W; 144072

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will put in place a strategy for tackling headlice similar to the one in place in Scotland.

Asked by

David Drew (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 December 2003

Reference

143031; 415 c995W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps he proposes to take to prevent people from dying from fatal cardiac arhythmias. - Inc figure.

Asked by

Lord Pickles (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

17 December 2003

Reference

143978; 415 c989W

House

House of Commons

Dept for International Development

Answered by

Hilary Benn (Labour)

Answering body

Department for International Development

Type

Oral answers to questions

Date

17 December 2003

Reference

415 c1557-8

House

House of Commons

Dept for International Development

Answered by

Hilary Benn (Labour)

Answering body

Department for International Development

Type

Oral answers to questions

Date

17 December 2003

Reference

415 c1557-8

House

House of Commons

Dept for International Development

1st supplementary on helping the Iraqi Red Crescent to send children for treatment outside Iraq. - Inc figures.

Asked by

Cheryl Gillan (Conservative)

Answering body

Department for International Development

Oral questions - 1st Supplementary

Status

Answered

Date

17 December 2003

Reference

415 c1557-8

House

House of Commons

Dept for International Development

To ask the Secretary of State for International Development, what recent representations he has received about aid to Iraq; and if he will make a statement.

Asked by

Cheryl Gillan (Conservative)

Answering body

Department for International Development

Oral questions - Lead

Status

Answered

Date

17 December 2003

Reference

415 c1557-8; 144409

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make it his policy that every patient recommended by an NHS consultant for brachytherapy treatment has the treatment funded by a primary care trust; what the Government's policy on the funding of brachytherapy treatment by the National Health Service...

Asked by

Christopher Chope (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 December 2003

For answer on

16 December 2003

Answered on

16 December 2003

Mr. Chope: To ask the Secretary of State for Health (1) if he will make it his policy that every patient recommended by an NHS consultant for brachytherapy treatment has the treatment funded by a primary care trust; [144545] (2) what the Government's policy on the funding of brachytherapy treatment by the national health service is. [144546] Miss Melanie Johnson: The National Institute of Clinical Excellence (NICE) published guidance on the organisation and delivery of services for people with urological cancers, including prostate cancer, in September 2002. The guidance states that the option of brachytherapy should be discussed with men with early prostate cancer. However, the NICE guidance also acknowledges that, the place of brachytherapy in the treatment of prostate cancer is uncertain and notes the importance of research to evaluate the effectiveness of brachytherapy for prostate cancer. The guidance refers to a randomised intergroup trial comparing brachytherapy with radical surgery that is being organised by the National Cancer Institute of Canada and the American College of Surgeons Oncology Group, and strongly encourages UK participation in this study. As a result, the Department of Health has made available £900,000 through the National Cancer Research Network (NCRN) to enable national health service patients to enter this trial. The National Cancer Research Institute (NCRI) prostate cancer clinical studies group and the NCRN are working closely together to take this trial forward in the NHS. As more evidence on the effectiveness and cost effectiveness of brachytherapy becomes available, the Department will consider whether this treatment is a suitable topic for referral to NICE as a technology appraisal. The Government are devolving power from the centre to enable primary care trusts to use the extra resources for the NHS to deliver on both national and local priorities for their communities, accounting publicly for how they have used them.

Date

16 December 2003

Reference

415 c876-7W; 144545;144546

House

House of Commons

Librarians' tools

Type

House

Session

Month

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher